Syngeneic bone marrow cell therapy prevents intimal proliferation in allogeneic vascular transplantation

Journal of Surgical Research

Volumn 168, Issue 1, 2011, Pages 143-148

  Freguin Bouilland, Caroline ^a   Alkhatib, Bassam ^a   David, Nathalie ^a   Lallemand, Françoise ^a   Bessou, Jean Paul ^a   Boyer, Olivier ^a   Thuillez, Christian ^a   Plissonnier, Didier ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

arteries; cell therapy; stem cells; transplantation

Indexed keywords

CD34 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FUCAN; POLYSACCHARIDE SULFATE; UNCLASSIFIED DRUG;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR DISEASE;

ANIMALS; ANTIGENS, CD34; AORTA; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; MALE; MODELS, ANIMAL; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, INBRED BN; RATS, INBRED LEW; TISSUE THERAPY; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC; TUNICA INTIMA; VASCULAR GRAFTING;

EID: 79955596609     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.10.018     Document Type: Article

References (29)

1. Hillebrands JL, Klatter FA, van den Hurk BMH, et al. Origin of neointimal endothelium and α-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest 2001;107:1411.
2. Häyry P. Chronic allograft rejection. Immunol Rev 1993;134:33.
3. Saiura A, Sata M, Hirata Y, et al. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med 2001;7:382.
4. Shimizu K, Sugiyama S, Aikawa M, et al. Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat Med 2001;7:738.
5. Grimm PC, Nickerson P, Jeffery J, et al. Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection. N Engl J Med 2001;345:93.
6. Quaini F, Urbanek K, Beltrami AP. Chimerism of the transplanted heart. N Eng J Med 2002;346:5.
7. Lalor PF, Adams DH. Lymphocyte homing to allografts. Transplantation 2000;70:1131.
8. Werner N, Priller J, Laufs U, et al. Bone marrow-derived progenitor cells modulate vascular re-endothelialization and neointimal formation: Effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 2002;22:1567.
9. Gomez D, Louedec L, Plissonnier D, et al. Endoluminal smooth muscle cell seeding limits intimal hyperplasia. J Vasc Surg 2001;34:707.
10. Hillebrands JL, Onuta G, Rozing J. Role of progenitor cells in transplant arteriosclerosis. Trends Cardiovasc Med 2005;15:1.
11. Han CI, Campbell GR, Campbell JH. Circulating bone marrow cells can contribute to neointimal formation. J Vasc Res 2001;38:113.
12. Sata M. Circulating vascular progenitor cells contribute to vascular repair, remodeling, and lesion formation. Trends Cardiovasc Med 2003;13:249.
13. Hillebrands JL, Klatter FA, Rozing J. Origin of vascular smooth muscle cells and the role of circulating stem cells in transplant arteriosclerosis. Arterioscler Thromb Vasc Biol 2003;23:380.
14. Li M, Losordo DW. Transplant graft vasculopathy: A dark side of bone marrow stem cells? Circulation 2003;108:3056.
15. Gulati R, Simari RD. Autologous cell-based therapies for vascular disease. Trends Cardiovasc Med 2004;14:262.
16. Alkhatib B, Freguin-Bouilland C, Lallemand F, et al. Low molecular weight fucan prevents transplant coronaropathy in rat cardiac allograft model. Transpl Immunol 2006;16:14.
17. Freguin-Bouilland C, Alkhatib B, David N, et al. Low molecular weight fucoidan prevents neointimal hyperplasia after aortic allografting. Transplantation 2007;83:1234.
18. Plissonnier D, Levy B, Salzmann JL, et al. Allograft-induced arterial wall injury and response in normotensive and spontaneously hypertensive rats. Arterioscler Thromb 11 1991;11:1690.
19. Plissonnier D, Nochy D, Poncet P, et al. Sequential immunological targeting of chronic experimental arterial allograft. Transplantation 1995;60:414.
20. Plissonnier D, Henaff M, Poncet P, et al. Involvement of antibody-dependent apoptosis in graft rejection. Transplantation 2000;69:2601.
21. Rookmaaker MB, Vergeer M, van Zonneveld AJ, et al. Endothelial progenitor cells: Mainly derived from the monocyte/macrophage-containing CD34- mononuclear cell population and only in part from the hematopoietic stem cell-containing CD34+ mononuclear cell population. Circulation 2003;108:e150.
22. Friedrich EB, Walenta K, Scharlau J, et al. CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res 2006;98:e20.
23. Kitamura T, Sata M, Motomura N, et al. Seeding of recipient bone marrow cells reduces neointimal hyperplasia of de-endothelialized rat aortic allograft. Int Heart J 2005;46:303.
24. Ciancio G, Miller J, Garcia-Morales RO, Carreno M, et al. Six-year clinical effect of donor bone marrow infusions in renal transplant patients. Transplantation 2001;71:827.
25. Bigaud M, Schraa EO, Andreambeloson E, et al. Complete loss of functional smooth muscle cells precedes vascular remodelling in rat aorta allografts. Transplantation 1999;68:1701.
26. Sweeney EA, Lortat-Jacob H, Priestley GV, et al. Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: Involvement in mobilization of stem/progenitor cells. Blood 2002;99:44.
27. Hillebrands J, Hurk BMVD, Klatter FA, et al. Recipient origin of neointimal vascular smooth muscle cells in cardiac allografts with transplant arteriosclerosis. J Heart Lung Transplant 2000;19:1183.
28. Lin Y, Weisdorf D, Solovey A, et al. Origin of circulating endothelial cells and endothelial outgrowth from blood. J Clin. Invest 2000;105:71.
29. Hu Y, Zhang Z, Torsney E, et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest 2004;113:1258.